Journal club

Created using ChatSlide

This review examines the impact of prenatal opioid agonist therapy (OAT) on maternal and neonatal health, focusing on methadone versus buprenorphine. Utilizing PRISMA 2020 guidelines, the study analyzed 5,520 records, ultimately including 27 studies. Results indicate that buprenorphine significantly reduces the risk of preterm birth and low birthweight, with relative risks of 0.63 and 0.48, respectively. These findings underscore the importance of OUD care in improving outcomes for mothers...